Št. zadetkov: 50
Kratki znanstveni prispevek
Oznake:
polycystic ovary syndrome;obesity;glucagon-like peptide-1 receptor agonists;
Leto:
2024
Vir:
Medicinska fakulteta (UL MF)
Izvirni znanstveni članek
Oznake:
metformin;PCOS;semaglutide;maintenance;obesity;weight regain;
Background: Withdrawal of semaglutide is frequently followed by weight regain due to compensatory biological changes that prevent the maintenance of long-term weight loss. There are some studies implying that metformin might attenuate weight regain. The weight trajectory after discontinuation of sho ...
Leto:
2024
Vir:
Digitalni repozitorij raziskovalnih organizacij Slovenije
Pregledni znanstveni članek
Oznake:
prolonged fasting;endocrine adaptations;metabolic switch;
Objectives: Intermittent fasting regimens that include periods of prolonged fasting may mimic certain well-documented benefits of calorie restriction. In this narrative review, we synthesize preclinical and human data on endocrine adaptations during prolonged fasting protocols. Methods: We conducted ...
Leto:
2025
Vir:
Digitalni repozitorij raziskovalnih organizacij Slovenije
Izvirni znanstveni članek
Oznake:
PCOS;debelost;semaglutid;obesity;semaglutide;
Context: Semaglutide could contribute to reduced energy intake and weight loss by delaying gastric emptying (GE). However, the evidence for notable effects of semaglutide is inconclusive and compromised by the use of indirect methodology. Objective: to evaluate the effect of once-weekly subcutaneous ...
Leto:
2023
Vir:
Digitalni repozitorij raziskovalnih organizacij Slovenije
Poljudni članek
Oznake:
Metabolični sindrom včeraj, danes, jutri
Leto:
2007
Vir:
Centralna tehniška knjižnica Univerze v Ljubljani (CTK)
Izvirni znanstveni članek
Oznake:
zapleti sladkorne bolezni;preprečevanje debelosti;staranje;diabetes complications;obesity prevention;aging;
: Type 1 (T1D) and type 2 diabetes (T2D) are determinants of health-related outcomes including health-related quality of life (HRQOL). We aimed to determine differences in HRQOL between older adults with T1D and T2D and specific factors influencing HRQOL in this age group. This study used a cross-se ...
Leto:
2023
Vir:
Digitalni repozitorij raziskovalnih organizacij Slovenije
Doktorska disertacija
Oznake:
PCOS;prediabetes;GLP-1 response;DPP-4 inhibitor;sitagliptin;weight maintenance;GLP-1 receptor agonist;liraglutide;
Obesity is highly prevalent in polycystic ovary syndrome (PCOS). It worsens reproductive and metabolic abnormalities of the syndrome, in particular insulin resistance (IR), Weight manegment and decreasing IR with lifestyle modification and metformin are well-addressed targets in this population, yet ...
Leto:
2018
Vir:
Medicinska fakulteta (UL MF)
Pregledni znanstveni članek
Oznake:
glukagonu podoben peptid 1 (GLP-1);okus;jezik;debelost;sladko;glucagon-like peptide 1 (GLP-1);taste;tongue;obesity;sweet;
Preclinical studies provided some important insights into the action of glucagon-like peptide 1 (GLP-1) in taste perception. This review examines the literature to uncover some molecular mechanisms and connections between GLP-1 and the gustatory coding. Local GLP-1 production in the taste bud cells, ...
Leto:
2021
Vir:
Medicinska fakulteta (UL MF)
Doktorska disertacija
Oznake:
funkcionalni hipogonadizem;debelost;sladkorna bolezen;semaglutid;GLP-1 RA;testosteron;semenska tekočina;
Uvod: Funkcionalni hipogonadizem pogosto prizadane moške s sladkorno boleznijo tipa 2 in debelostjo. Nadomestno zdravljenje s testosteronom pomembno izboljša simptome hipogonadizma in raven testosterona, vendar lahko negativno vpliva na spermatogenezo. Učinki agonistov receptorjev glukagonu podobneg ...
Leto:
2025
Vir:
Medicinska fakulteta (UL MF)
Pregledni znanstveni članek
Oznake:
in-patient diabetes;continuous glucose monitoring (CGM);in-patient diabetes technology;
Background: The use of continuous glucose monitoring (CGM) offers several benefits. Compared to point-of-care (POC) capillary glucose tests, user acceptability is greater, and time in the target glucose range is improved. If these advantages can be transferred from outpatient to in-patient settings, ...
Leto:
2026
Vir:
Digitalni repozitorij raziskovalnih organizacij Slovenije